---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-23-000334"
form_type: "8-K"
ticker: "CCRN"
cik: "0001141103"
company_name: "CROSS COUNTRY HEALTHCARE INC"
filed_at: "2023-02-22T23:59:59+00:00"
generated_at: "2026-06-19T04:13:45.711251+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cross Country Healthcare Q4 revenue down 2% YoY; guides Q1 revenue down ~25% YoY

## Summary
- Q4 revenue $628.2M (-2% YoY); net income $38.8M (-50% YoY); diluted EPS $1.05 vs $2.07.
- Full year 2022 revenue $2.8B (+67% YoY); net income $188.5M (+43% YoY); adjusted EBITDA $301.7M (+86%).
- Q1 2023 guidance: revenue $590-600M (down ~25% YoY); adjusted EBITDA $44-49M (down ~50% YoY).
- Completed acquisitions of Mint, Lotus, and HireUp in Q4; repurchased 0.4M shares for $10.9M.
- Made $100M optional prepayments on term loan in 2022; remaining $76.2M share repurchase authorization.

## SEC filing metadata
- accession: 0001157523-23-000334
- form_type: 8-K
- ticker: CCRN
- cik: 0001141103
- company_name: CROSS COUNTRY HEALTHCARE INC
- filed_at: 2023-02-22T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1141103/000115752323000334/0001157523-23-000334-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1141103/000115752323000334/a53334950.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-23-000334
- JSON: https://secwatch.observer/filing/0001157523-23-000334.json
- Plain text: https://secwatch.observer/filing/0001157523-23-000334.txt

## Key facts
- Earnings Releases
  CROSS COUNTRY HEALTHCARE INC reported the full year ended December 31, 2022 results: revenue $2.8 billion, net income $188.5 million, EPS 5.02.
  - Period: the full year ended December 31, 2022
  - Revenue: $2.8 billion
  - Net income: $188.5 million
  - EPS: 5.02
  - Result: reported results
  source text: For the year ended December 31, 2022, consolidated revenue was $2.8 billion, an increase of 67% year-over-year. Consolidated gross profit margin was 22.4%, consistent with the prior year. Net income attributable to common stockholders was $188.5 million, or 5.02 per diluted share, compared to $132.0 million, or $3.53 per diluted share, in the prior year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1141103/000115752323000334/0001157523-23-000334-index.htm
- Earnings Releases
  CROSS COUNTRY HEALTHCARE INC reported the fourth quarter ended December 31, 2022 results: revenue $628.2 million, net income $38.8 million, EPS $1.05.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $628.2 million
  - Net income: $38.8 million
  - EPS: $1.05
  - Result: reported results
  source text: Fourth quarter consolidated revenue was $628.2 million, a slight decrease from the prior year and prior quarter. Consolidated gross profit margin was 22.1%, down 90 basis points year-over-year and 50 basis points sequentially. Net income attributable to common stockholders was $38.8 million compared to $77.6 million in the prior year and $34.8 million in the prior quarter. Diluted earnings per share (EPS) was $1.05 compared to $2.07 in the prior year and $0.93 in the prior quarter.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1141103/000115752323000334/0001157523-23-000334-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.